Iradimed Corporation (NASDAQ:IRMD – Get Free Report) declared a quarterly dividend on Thursday, October 31st,Zacks Dividends reports. Stockholders of record on Friday, November 15th will be given a dividend of 0.15 per share by the medical equipment provider on Monday, November 25th. This represents a $0.60 annualized dividend and a dividend yield of 1.05%. The ex-dividend date is Friday, November 15th.
Iradimed has a payout ratio of 34.3% meaning its dividend is sufficiently covered by earnings. Analysts expect Iradimed to earn $1.59 per share next year, which means the company should continue to be able to cover its $0.60 annual dividend with an expected future payout ratio of 37.7%.
Iradimed Price Performance
Iradimed stock opened at $56.95 on Wednesday. The firm has a market capitalization of $721.56 million, a PE ratio of 39.01 and a beta of 0.79. The company’s 50-day moving average is $50.12 and its 200-day moving average is $46.25. Iradimed has a fifty-two week low of $39.24 and a fifty-two week high of $57.95.
Analyst Ratings Changes
Read Our Latest Research Report on IRMD
About Iradimed
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.
See Also
- Five stocks we like better than Iradimed
- How to Read Stock Charts for Beginners
- 3 Solar Stocks at Bargain Prices: Big Opportunities Ahead
- What Are Dividend Achievers? An Introduction
- Is Bitcoin’s Trump Card a Boom or Bust?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Cloudflare Is a Solid Buy for 2025
Receive News & Ratings for Iradimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iradimed and related companies with MarketBeat.com's FREE daily email newsletter.